See the TOP 100 Drug IV-Rating for Products Promoted on the Russian Pharmaceutical Market
Posted on: Friday, 10 February 2006, 09:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c32687) has announced the addition of Russia's Current Pharmaceutical Market Demand: Quarter 4 2005 to their offering.
This report contains detailed information on consumer demand on Russian pharmaceutical market (RPM). The report includes TOP-100 drug Iv-rating for products promoted on the RPM, 100 Iv graphs for each drug of the TOP-100 rating for the latest 6 months together with TOP-50 Iv-rating of the main RPM players.
This report is useful for:
-- Analysis of current processes on RPM;
-- Sales forecast;
-- Effective feedback for control of large advertising campaigns;
-- Monitoring of competitors' marketing activity.
Use the TOP-100 drug Iv-rating for quick analysis of the situation around sales-leading products and to form a picture of buyers' dominating preferences in Russia. The TOP-50 Iv-rating of the Russian Pharmaceutical Market's main players provides a quick guide of key market participants' rating as far as demand for their products is concerned.
The level of consumer demand is evaluated by means of information demand (ID) indicators. These indicators are calculated on the basis of the analysis of search traffic data of the site www.rlsnet.ru - the corporate site of "RLS - Russian Drug Directory", the leading publisher of medical directories (annual circulation - over 350 000 copies) in Russia.
The site provides free web-access to a data base containing complete information on all medicines present in the Russian Pharmaceutical Market RPM (over 2 000 000 search queries on medicines monthly). www.rlsnet.ru is the visitation leader of the Russian "pharmaceutical" Internet segment, thus can provide a complete picture of consumers' preferences in Russia (structure and parameters of the visitors traffic are shown in the chapter "Who requests drug information on www.rlsnet.ru". Selected respondents spectrum").
Topics covered in the report include:
-- TOP-100 Iv rating for drugs on Russian pharmaceutical market
-- 100 last 6 month Iv diagrams for members of TOP-100 rating
-- TOP-50 Iv rating for key market players on Russian pharmaceutical market
-- Who enquires drug information on www.rlsnet.ru. Selected respondents spectrum
-- Samples of Demand-Sales correlation
For more information visit http://www.researchandmarkets.com/reports/c32687
Source: Business Wire
Related Articles
- Reportlinker Adds Chinese Markets for Cervical Cancer Treatment Drugs
- Genstruct to Present Results of Collaboration with Top Pharmaceutical Company at American Association for Cancer Research's Annual Meeting
- The Cost Of Running Trials Approaches 30% Of Pharmaceutical Companies' Entire Drug Development Budgets, However 75% Of Patient Studies Fail To Make Their Timelines
- Pro-Pharmaceuticals Submits Orphan Drug Status Application to European Medicines Agency Co-Administration of DAVANAT(R) With 5-FU to Treat Cholangiocarcinoma
- The 'Generic Handbook 2007' Contains Detailed Product Analysis on Over 200 Top Generic Drugs, and Profiles of the Top 75 US Generic Drug Companies Including Financial Data and Contact Information
- Global Sales of ADHD Drugs Are Forecast to Reach US$4.3 Billion By 2012 - Market Research Available on CNS Drug Discoveries 2006: Attention Deficit Hyperactivity Disorder
- Identify the 100 Leading Drugs That Are Expected to Be Launched By 2011
- KV Pharmaceutical in Generic Drug Deal With Gedeon
- Research and Markets : Pharmaceuticals Capacity, Output and Demand in Chinese Market With Forecasts Up to 2014
- Encysive Pharmaceuticals Submits New Drug Application for Thelin(TM)
 |
 |
User Comments (0)
RSS Feeds